Search

Pioneering professor performs 30,000th laser eye procedure

A Moorfields Eye Hospital NHS Foundation Trust and Moorfields Private Hospital consultant has performed his 30,000th refractive laser eye procedure (at Moorfields Private), 36 years after he carried out the first of its kind in the UK. In 1989, while...

MicroPulse Transscleral Laser Therapy: A Prospective UK Study

Register now to participate. Eagerly anticipated and now underway – a landmark UK medical research study on MicroPulse® Transscleral Laser Therapy (MPTLT) for the treatment of glaucoma using Iridex’ Cyclo G6® Laser and the MicroPulse P3® Delivery Device. A NICE-compliant...

Dr Paul Singh and Prof Gus Gazzard on laser as first line therapy

Both the American Academy of Ophthalmology (AAO) and the European Glaucoma Society (EGS) have updated their preferred practice regimens to recognize or recommend SLT as an initial intervention for glaucoma and the NICE UK are now guiding doctors to use SLT before drops.

Study shows laser treatment could significantly improve treatment for glaucoma in Africa

Results of a trial published in Lancet Global Health on 14/10/21 could pave the way for significant improvements in treatment for glaucoma in Sub-Saharan Africa.

1/3 UK considering laser eye surgery but majority unaware it's non-reversible and affects night vision

National eye health survey shows a third of UK are considering laser eye surgery but vast majority are unaware it is non-reversible and how it can affect night vision.

First UK Direct Selective Laser Trabeculoplasty (DSLT) device placed at Moorfields

Following an internationally successful Randomised Controlled Trial (RCT) comparing the Direct Selective Laser Trabeculoplasty (DSLT) with standard SLT, the first ever commercial device in the UK, the ‘Eagle’, has been installed and is in use at Moorfields Eye Hospital in London.

BELKIN Vision is pleased to announce FDA clearance for its glaucoma laser, the Eagle device

BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.

The National Treatment Centre-Highland

The National Treatment Centre-Highland opened its doors to patients in April 2023. At a cost of £48 million this represented a significant investment by the Scottish Government for the provision of modern eye care for the North of Scotland.

Landmark review of glaucoma treatment and research published by Moorfields-led team

Four world-leading experts, including Hari Jayaram and Gus Gazzard from Moorfields, have combined their knowledge with the findings from over 150 peer-reviewed study publications to produce a landmark paper published in the Lancet.

"Just a ‘thank you’ would be enough", says Belfast nurse

A nurse from Belfast who had her glasses broken by a patient has been given free laser eye surgery, in a campaign to thank frontline workers.

The NRC achieves Carbon Neutrality for the second year running

The NRC has successfully achieved carbon neutrality for 2022, alongside a significant reduction in emissions in a number of areas.

Discovery Park Ventures invests £100K in new tenant Vox Imaging Technology

Discovery Park Ventures invests £100K in new tenant Vox Imaging Technology to advance ophthalmic imaging for preclinical research.